Citation 88282

ATTA-UR-RAHMAN: ZAHEER UL HAQ: KHALID,A: ANJUM,S: KHAN,MR: CHOUDHARY,MI:. (2002). PREGNANE-TYPE STEROIDAL ALKALOIDS OF SARCOCOCCA SALIGNA: A NEW CLASS OF CHOLINESTERASE INHIBITORS.. 85(2)

Citation Details

Title	PREGNANE-TYPE STEROIDAL ALKALOIDS OF SARCOCOCCA SALIGNA: A NEW CLASS OF CHOLINESTERASE INHIBITORS.
Authors	ATTA-UR-RAHMAN: ZAHEER UL HAQ: KHALID,A: ANJUM,S: KHAN,MR: CHOUDHARY,MI:
Year	2002
Volume	85
Issue	2

Summary

Year: 2002

Journal: Unknown

Organisms and Their Experiments (1)

Sarcococca saligna (BUXACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	SALIGNENAMIDE C	None
2	ACETYLCHOLINESTERASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	SALIGNENAMIDE C	ACTIVE
3	BUTYRYLCHOLINESTERASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	SALIGNENAMIDE C	ACTIVE
4	ANTICRUSTACEAN ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SALIGNENAMIDE C	INACTIVE
5	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	SALIGNENAMIDE D	None
6	ACETYLCHOLINESTERASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	SALIGNENAMIDE D	ACTIVE
7	BUTYRYLCHOLINESTERASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	SALIGNENAMIDE D	ACTIVE
8	ANTICRUSTACEAN ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SALIGNENAMIDE D	INACTIVE
9	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	PACHYSAMINE,EPI: 2-BETA-HYDROXY:	None
10	ACETYLCHOLINESTERASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PACHYSAMINE,EPI: 2-BETA-HYDROXY:	ACTIVE
11	BUTYRYLCHOLINESTERASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PACHYSAMINE,EPI: 2-BETA-HYDROXY:	ACTIVE
12	ANTICRUSTACEAN ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	PACHYSAMINE,EPI: 2-BETA-HYDROXY:	INACTIVE
13	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	SALIGNENAMIDE E	None
14	ACETYLCHOLINESTERASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	SALIGNENAMIDE E	ACTIVE
15	BUTYRYLCHOLINESTERASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	SALIGNENAMIDE E	ACTIVE
16	ANTICRUSTACEAN ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SALIGNENAMIDE E	INACTIVE
17	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	SALIGNENAMIDE F	None
18	ACETYLCHOLINESTERASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	SALIGNENAMIDE F	ACTIVE
19	BUTYRYLCHOLINESTERASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	SALIGNENAMIDE F	ACTIVE
20	ANTICRUSTACEAN ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SALIGNENAMIDE F	INACTIVE
21	Not specified	ISOLATION AND IDENTIFICATION OF	AXILLARINE C	None
22	ACETYLCHOLINESTERASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	AXILLARINE C	WEAK ACTIVITY
23	BUTYRYLCHOLINESTERASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	AXILLARINE C	ACTIVE
24	ANTICRUSTACEAN ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	AXILLARINE C	INACTIVE
25	Not specified	ISOLATION AND IDENTIFICATION OF	AXILLARINE F	None
26	ACETYLCHOLINESTERASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	AXILLARINE F	WEAK ACTIVITY
27	BUTYRYLCHOLINESTERASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	AXILLARINE F	ACTIVE
28	ANTICRUSTACEAN ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	AXILLARINE F	INACTIVE
29	Not specified	ISOLATION AND IDENTIFICATION OF	SARCORINE	None
30	ACETYLCHOLINESTERASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	SARCORINE	ACTIVE
31	BUTYRYLCHOLINESTERASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	SARCORINE	ACTIVE
32	ANTICRUSTACEAN ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SARCORINE	INACTIVE
33	Not specified	ISOLATION AND IDENTIFICATION OF	SARACODINE,N(3)-DEMETHYL:	None
34	ACETYLCHOLINESTERASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	SARACODINE,N(3)-DEMETHYL:	WEAK ACTIVITY
35	BUTYRYLCHOLINESTERASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	SARACODINE,N(3)-DEMETHYL:	ACTIVE
36	ANTICRUSTACEAN ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SARACODINE,N(3)-DEMETHYL:	INACTIVE
37	Not specified	ISOLATION AND IDENTIFICATION OF	SALIGCINNAMIDE	None
38	ACETYLCHOLINESTERASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	SALIGCINNAMIDE	ACTIVE
39	BUTYRYLCHOLINESTERASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	SALIGCINNAMIDE	ACTIVE
40	ANTICRUSTACEAN ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SALIGCINNAMIDE	INACTIVE
41	Not specified	ISOLATION AND IDENTIFICATION OF	SALIGNENAMIDE A	None
42	ACETYLCHOLINESTERASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	SALIGNENAMIDE A	ACTIVE
43	BUTYRYLCHOLINESTERASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	SALIGNENAMIDE A	ACTIVE
44	ANTICRUSTACEAN ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SALIGNENAMIDE A	INACTIVE
45	Not specified	ISOLATION AND IDENTIFICATION OF	VAGANINE A	None
46	ACETYLCHOLINESTERASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	VAGANINE A	ACTIVE
47	BUTYRYLCHOLINESTERASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	VAGANINE A	ACTIVE
48	ANTICRUSTACEAN ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	VAGANINE A	INACTIVE
49	Not specified	ISOLATION AND IDENTIFICATION OF	AXILLARIDINE A	None
50	ACETYLCHOLINESTERASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	AXILLARIDINE A	ACTIVE
51	BUTYRYLCHOLINESTERASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	AXILLARIDINE A	ACTIVE
52	ANTICRUSTACEAN ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	AXILLARIDINE A	INACTIVE
53	ACETYLCHOLINESTERASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	SARSALIGNONE	ACTIVE
54	BUTYRYLCHOLINESTERASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	SARSALIGNONE	ACTIVE
55	ANTICRUSTACEAN ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SARSALIGNONE	INACTIVE
56	ACETYLCHOLINESTERASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	SARSALIGNENONE	ACTIVE
57	BUTYRYLCHOLINESTERASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	SARSALIGNENONE	ACTIVE
58	ANTICRUSTACEAN ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SARSALIGNENONE	INACTIVE

Citation 88282

Citation Details

Summary

Organisms and Their Experiments (1)

Sarcococca saligna (BUXACEAE)

Show SPARQL Queries (1)

Query 1